Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Ferring Investigational Site, Mobile, Alabama Ferring Investigational Site, San Diego, California Ferring Investigational Site, Baltimore, Maryland Ferring Investigational Site, Baltimore, Maryland Ferring Investigational Site, The Bronx, New York